# Accused Notary Takes Stand in Nebraska Medical Cannabis Petition Fraud Trial > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/fraudulent-medical-cannabis-petition-signatures-nebraska-trial/ > **Published:** 2026-04-25T02:26:25-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:58:37-04:00 > **Clinical Summary:** A Nebraska notary faces trial for fraudulent medical cannabis petition signatures, raising concerns about petition verification and program integrity. --- ✦ New CED Clinical Relevance #5 [Clinical Context](https://cedclinic.com/cannabis-hyperemesis-syndrome-treatment-insights-2026/) Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicyIndustrySafety Clinical Summary A notary public in Nebraska has become the defendant in a criminal trial involving fraudulent [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) petition signatures, raising concerns about the integrity of the state’s [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) application process. The case centers on allegations that the notary notarized signatures on medical cannabis petitions without properly verifying that the signatories were actually present or had authorized their signatures, a fundamental requirement for legitimate notarization. This scandal directly undermines the credibility of Nebraska’s emerging medical cannabis program and highlights systemic vulnerabilities in how applications are vetted before reaching state regulators. For clinicians seeking to participate in or refer patients to a state medical cannabis program, such regulatory lapses suggest that oversight mechanisms may be inadequate to ensure only legitimate patients and providers gain access. Patients relying on medical cannabis may question whether their fellow program participants have been properly vetted, potentially affecting their confidence in the program’s legitimacy and safety standards. Clinicians should remain vigilant about documentation and verification procedures in any medical cannabis program and consider advocating for stronger state-level safeguards to prevent fraud that could jeopardize [patient access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/) or program survival. Dr. Caplan’s Take “When we’re dealing with fraudulent documentation in the medical cannabis space, we’re not just talking about a paperwork problem; we’re talking about patients who may not have genuine medical need accessing controlled substances, which undermines the credibility of legitimate [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and makes it harder for physicians like myself to help the patients who truly benefit from this therapy.” Clinical Perspective This case involving fraudulent medical cannabis documentation underscores a critical vulnerability in state-level medical cannabis programs where verification systems remain inconsistent and enforcement mechanisms may lag behind regulatory growth. Healthcare providers should be aware that fraudulent medical cannabis certifications—whether through forged notarizations, falsified patient records, or credential misrepresentation—can expose their practices to legal liability and undermine the legitimacy of medical cannabis as a therapeutic tool. The incident reflects broader challenges in [cannabis regulation](https://cedclinic.com/marijuana-rescheduling-regulatory-updates-march-2026/), including variable state standards for patient qualification, the absence of standardized credentialing processes for cannabis-recommending clinicians, and limited coordination between medical boards and law enforcement. Clinicians who recommend or certify patients for medical cannabis should verify their own licensure requirements, maintain rigorous documentation practices, and be mindful that documentation fraud—even if perpetrated by third parties—can implicate their medical judgment and professional standing. Establishing clear institutional protocols for cannabis certifications 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Accused%20notary%20for%20Nebraska%20medical%20%3Cb%3Ecannabis%3C%2Fb%3E%20petitions%20takes%20stand%20in%20criminal%20trial%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Faccused-notary-for-nebraska-medical-cannabis-petitions-takes-stand-in-criminal-trial%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Faccused-notary-for-nebraska-medical-cannabis-petitions-takes-stand-in-criminal-trial%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Accused%20notary%20for%20Nebraska%20medical%20%3Cb%3Ecannabis%3C%2Fb%3E%20petitions%20takes%20stand%20in%20criminal%20trial%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Faccused-notary-for-nebraska-medical-cannabis-petitions-takes-stand-in-criminal-trial%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Notary for Nebraska medical cannabis petitions found guilty of all 24 criminal charges](https://cedclinic.com/notary-fraud-medical-cannabis-nebraska-case/) Details on the conviction of the notary involved in fraudulent medical cannabis petitions in Nebraska. [Read the full verdict](https://cedclinic.com/notary-fraud-medical-cannabis-nebraska-case/) Nebraska Medical Cannabis Regulations Advance to State Leaders Updates on the progress of medical cannabis regulations in Nebraska amidst ongoing legal challenges. Learn about regulatory changes [Report: Kentucky’s Office of Medical Cannabis was ‘fair and transparent’ in licensing process](https://cedclinic.com/report-kentuckys-office-of-medical-cannabis-was-fair-and-transparent-in-licensing-process/) A comparative look at medical cannabis licensing transparency in Kentucky, relevant to regulatory discussions. [Explore licensing transparency](https://cedclinic.com/report-kentuckys-office-of-medical-cannabis-was-fair-and-transparent-in-licensing-process/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).